Corium to Report Third Quarter Fiscal Year 2016 Financial Results on Thursday, August 4, 2016
MENLO PARK, Calif. , July 28, 2016 (GLOBE NEWSWIRE) — Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the third fiscal quarter ended June 30, 2016 on Thursday, August 4, 2016 after the close of the U.S….

Corium Presents Full Clinical Results from Phase 1 Pharmacokinetic Study of Once-weekly Corplex^TM Donepezil Transdermal System
Positive Data Supporting Once-weekly Corplex Donepezil as Therapeutic Alternative to Daily Oral Aricept® Presented at Alzheimer’s Association International Conference® 2016…

Corium to Present Clinical Data from a Phase 1 Pharmacokinetic Study of Once-Weekly Corplex^TM Donepezil Transdermal System
Results to be presented at Alzheimer’s Association International Conference® 2016…

Corium to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
MENLO PARK, Calif. , July 05, 2016 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Peter Staple , Corium’s…